Skip to content

News

Women with Medicare Found to Have Low Genetic Testing Rates

Women with Medicare Found to Have Low Genetic Testing Rates

(August 23, 2018) Researchers from Vanderbilt Institute for Clinical and Translational Research recently conducted a study which focused on Medicare Part B recipients, those above the age of 65 or disabled, who were eligible for genetic testing. More specifically, they looked at women who had been seen at health centers in the Southeast United States … Continued

Mutation Patterns Predict Survival and Treatment Resistance...

Mutation Patterns Predict Survival and Treatment Resistance in Patients

(August 22, 2018) Several institutions in the UK recently published their project on finding patterns in DNA mutations. The tumors of 117 women, all of whom were diagnosed with high grade serous ovarian cancer, were processed by computer algorithms. Rather than looking at mutations within each DNA strand, the algorithm identified seven patterns of DNA … Continued

The new Super September, coming September 27-28th!

The new Super September, coming September 27-28th!

Maybe you attended Super Saturday in the Hamptons in the past. Or maybe you always wanted to but could never make it out there. Well, we’re transforming this iconic shopping event with a new name, a new look, a new location, and in a new month: September, ovarian cancer awareness month. At its core, Super … Continued

Analgesic Use Has Positive Effect in Ovarian Cancer Patients

Analgesic Use Has Positive Effect in Ovarian Cancer Patients

(July 30, 2018) Recently, two retrospective studies were published about the effects of analgesics, or pain relievers, on ovarian cancer. The information is actually a culmination of two studies, both of which have led researchers to believe that there is an association between regular use of analgesics and both reduced risk of, and increased survival … Continued

What You Need to Know About Talcum Powder and Ovarian Cancer

What You Need to Know About Talcum Powder and Ovarian Cancer

You may have seen headlines in April 2023 about Johnson & Johnson paying nearly $9 billion to tens of thousands of people who claim talcum powder caused their cancer, including ovarian cancer. Controversy around the connection between talcum powder and cancer has gone on for years and has generated thousands of lawsuits. Ovarian Cancer Research Alliance provides information … Continued

Denmark Study Shows Assisted Reproduction Does Not Increase...

Denmark Study Shows Assisted Reproduction Does Not Increase Risk of Ovarian Cancer

(July 12, 2018) A study involving 58,472 women between 1994 and 2015 concluded that assisted reproductive treatment, or ART, did not lead to an increased risk of ovarian cancer. Originally it was thought that the hormones used in ART would increase ovarian activity, which would in turn increase one’s risk of ovarian cancer. However, data … Continued

Research Updates from the 2018 American Society of Clinical...

Research Updates from the 2018 American Society of Clinical Oncology Annual Meeting

(July 2, 2018) Last month the American Society of Clinical Oncology (ASCO) held its annual meeting in Chicago, IL. Thirty nine thousand people from around the world attend to learn about the latest in cancer research. Ovarian cancer survivor and research advocate Annie Ellis attended the meeting and wrote a report highlighting some of the … Continued

FDA Approves Bevacizumab Paired with Chemotherapy After Sur...

FDA Approves Bevacizumab Paired with Chemotherapy After Surgery for Advanced Ovarian Cancer

(June 29, 2018) Avastin, or bevacizumab, was recently approved by the FDA to be used first with chemotherapy, then by itself, after surgery. A phase III trial studied 1,873 women who had not had any prior treatments for stage III or IV epithelial ovarian, primary peritoneal, or fallopian tube carcinoma. Once the women had undergone … Continued

Meet Sayla, OCRA Advocate Leader

Meet Sayla, OCRA Advocate Leader

Name: Sayla H.Hometown: Portland, ORStatus: In treatmentAdvocacy Goal: Oral Parity, Access to Care Sayla was diagnosed earlier last year and is currently in treatment. She’s determined to use her experience to help other women, and is empowered to advocate for women fighting ovarian cancer through OCRA’s Advocate Leader program. Tell us about your ovarian cancer … Continued

Meet Elise, OCRA Advocate Leader

Meet Elise, OCRA Advocate Leader

Name: Elise D.Hometown: Durham, NHStatus: 13-Year SurvivorAdvocacy Goal: Access to Care Elise feels lucky that she was diagnosed with early-stage ovarian cancer, and being an Advocate Leader allows her to fight for women who may not be able to fight for themselves. Tell us about your ovarian cancer journey. In the summer of 2005, I … Continued

Join Ovarian Cancer Survivors and Caregivers at OCRFA’...

Join Ovarian Cancer Survivors and Caregivers at OCRFA’s National Conference

Over 250 ovarian cancer survivors will travel from across the country to attend OCRFA’s Ovarian Cancer National Conference in Washington DC on July 13-15 Reserve your spot today and join our welcoming community of survivors, caregivers and experts for an inspirational weekend packed with empowering information and new friendships. Registration includes: Fun-filled receptions on Friday … Continued

Super Saturday Moves to September and New York City

Super Saturday Moves to September and New York City

(June 11, 2018) OCRFA, who has hosted Super Saturday in the Hamptons for the past 20 years is moving our iconic event to Manhattan. Super September will be held Thursday evening, September 27, and Friday, September 28. According to the New York Post, Page Six, “It’s the end of an era for Super Saturday. The … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.